Literature DB >> 30077998

NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy.

Junqin Sheng1, Hongyan Li2, Qin Dai1, Chang Lu1, Min Xu1, Jisheng Zhang1, Jianxun Feng1.   

Abstract

BACKGROUND/AIMS: Disrupted mitochondrial dynamics, including excessive mitochondrial fission and mitophagy arrest, has been identified as a pathogenic factor in diabetic nephropathy (DN), although the upstream regulatory signal for mitochondrial fission activation and mitophagy arrest in the setting of DN remains unknown.
METHODS: Wild-type (WT) mice and NR4A1 knockout (NR4A1-KO) mice were used to establish a DN model. Mitochondrial fission and mitophagy were evaluated by western blotting and immunofluorescence. Mitochondrial function was assessed by JC-1 staining, the mPTP opening assay, immunofluorescence and western blotting. Renal histopathology and morphometric analyses were conducted via H&E, Masson and PASM staining. Kidney function was evaluated via ELISA, western blotting and qPCR.
RESULTS: In the present study, we found that nuclear receptor subfamily 4 group A member 1 (NR4A1) was actually activated by a chronic hyperglycemic stimulus. Higher NR4A1 expression was associated with glucose metabolism disorder, renal dysfunction, kidney hypertrophy, renal fibrosis, and glomerular apoptosis. At the molecular level, increased NR4A1 expression activated p53, and the latter selectively stimulated mitochondrial fission and inhibited mitophagy by modulating Mff and Parkin transcription. Excessive Mff-related mitochondrial fission caused mitochondrial oxidative stress, promoted mPTP opening, exacerbated proapoptotic protein leakage into the cytoplasm, and finally initiated mitochondria-dependent cellular apoptosis in the setting of diabetes. In addition, defective Parkin-mediated mitophagy repressed cellular ATP production and failed to correct the uncontrolled mitochondrial fission. However, NR4A1 knockdown interrupted the Mff-related mitochondrial fission and recused Parkin-mediated mitophagy, reducing the hyperglycemia-mediated mitochondrial damage and thus improving renal function.
CONCLUSION: Overall, we have shown that NR4A1 functions as a novel malefactor in diabetic renal damage and operates by synchronously enhancing Mff-related mitochondrial fission and repressing Parkin-mediated mitophagy. Thus, finding strategies to regulate the balance of the NR4A1-p53 signaling pathway and mitochondrial homeostasis may be a therapeutic option for treating diabetic nephropathy in clinical practice.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Diabetic renal damage; Mff; Mitochondrial fission; Mitophagy; NR4A1; Parkin

Mesh:

Substances:

Year:  2018        PMID: 30077998     DOI: 10.1159/000492292

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  13 in total

Review 1.  Selective Autophagy in Hyperglycemia-Induced Microvascular and Macrovascular Diseases.

Authors:  Leena P Bharath; Jack Donato Rockhold; Rachel Conway
Journal:  Cells       Date:  2021-08-17       Impact factor: 6.600

2.  Huangqi-Danshen decoction alleviates diabetic nephropathy in db/db mice by inhibiting PINK1/Parkin-mediated mitophagy.

Authors:  Xinhui Liu; Jiandong Lu; Siqi Liu; Dakun Huang; Mianxiong Chen; Guoliang Xiong; Shunmin Li
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 3.  Loss of Mitochondrial Control Impacts Renal Health.

Authors:  Swayam Prakash Srivastava; Keizo Kanasaki; Julie E Goodwin
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

Review 4.  Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.

Authors:  Phoom Narongkiatikhun; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Cell Mol Med       Date:  2021-12-09       Impact factor: 5.310

Review 5.  Mitochondria in Diabetic Kidney Disease.

Authors:  Amna Ayesha Ahmad; Shayna Odeal Draves; Mariana Rosca
Journal:  Cells       Date:  2021-10-29       Impact factor: 6.600

Review 6.  Mitochondrial Regulation of Diabetic Kidney Disease.

Authors:  Daniel L Galvan; Koki Mise; Farhad R Danesh
Journal:  Front Med (Lausanne)       Date:  2021-09-27

Review 7.  New insights into the role of melatonin in diabetic cardiomyopathy.

Authors:  Keming Huang; Xianling Luo; Yi Zhong; Li Deng; Jian Feng
Journal:  Pharmacol Res Perspect       Date:  2022-02

Review 8.  Excessively Enlarged Mitochondria in the Kidneys of Diabetic Nephropathy.

Authors:  Kiyoung Kim; Eun-Young Lee
Journal:  Antioxidants (Basel)       Date:  2021-05-07

9.  Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.

Authors:  Yinqiu Wang; Aolei Niu; Yu Pan; Shirong Cao; Andrew S Terker; Suwan Wang; Xiaofeng Fan; Cynthia L Toth; Marisol A Ramirez Solano; Danielle L Michell; Danielle Contreras; Ryan M Allen; Wanying Zhu; Quanhu Sheng; Agnes B Fogo; Kasey C Vickers; Ming-Zhi Zhang; Raymond C Harris
Journal:  Diabetes       Date:  2021-07-07       Impact factor: 9.337

10.  NIPA2 regulates osteoblast function by modulating mitophagy in type 2 diabetes osteoporosis.

Authors:  Wei Zhao; Weilin Zhang; Hongdong Ma; Maowei Yang
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.